News Room

Events & Presentations

Upcoming Events

Evercore ISI Biopharma Catalyst/Deep Dive Conference
Boston, MA – November 29-30, 2017

Presentations

Madrigal Non-confidential Presentation November 9, 2017

MGL-3196, a β-Selective Thyroid Hormone Receptor (THR) Agonist, Demonstrates Metabolic, Anti-inflammatory and Anti-fibrotic Benefits in a Long-term High Fat Diet (HFD) Mouse NASH Model

Archived Events

Cowen Healthcare Conference
Boston, MA – March 8, 2017

ROTH Investor Conference
Laguna Niguel, CA – March 13, 2017

H.C. Wainwright NASH Investor Conference
New York, NY – April 3, 2017

Jefferies 2017 Healthcare Conference
New York, NY – June 6-9, 2017

JMP Securities Life Sciences Conference
New York, NY – June 20-21, 2017

HC Wainwright / Rodman & Renshaw Annual Healthcare Conference
New York, NY – September 10-12, 2017

Cantor Fitzgerald Healthcare Conference
New York, NY – September 25-27, 2017

AASLD Liver Meeting
Poster # 1969: MGL-3196, a β-Selective Thyroid Hormone Receptor (THR) Agonist, Demonstrates Metabolic, Anti-inflammatory and Anti-fibrotic Benefits in a Long-term High Fat Diet (HFD) Mouse NASH Model
Washington, DC – October 20-24, 2017

FIRST EASL NAFLD SUMMIT
Vitamin D, thyroid function (the obvious and neglected; including Liver-Directed Thyroid Hormone Receptor-β (THR-β) agonists
Rome, Italy – November 9-11, 2017

Jefferies 2017 London Healthcare Conference
London, UK – November 15-16, 2017

Discovery on Target Conference:
Thyroid Hormone Receptor Targets
Boston, MA – September 26, 2017